Global Radiopharmaceutical Theranostics Market Growth (Status and Outlook) 2023-2029

February 2023 | 103 pages | ID: G3DDE3EC2A9AEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

Nuclear medicine therapy uses radiopharmaceuticals targeting specific tumors, such as thyroid tumors, lymphomas, or bone metastases, to deliver radiation to neoplastic lesions as part of a therapeutic strategy to cure, alleviate, or control the disease.

LPI (LP Information)' newest research report, the “Radiopharmaceutical Theranostics Industry Forecast” looks at past sales and reviews total world Radiopharmaceutical Theranostics sales in 2022, providing a comprehensive analysis by region and market sector of projected Radiopharmaceutical Theranostics sales for 2023 through 2029. With Radiopharmaceutical Theranostics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Radiopharmaceutical Theranostics industry.

This Insight Report provides a comprehensive analysis of the global Radiopharmaceutical Theranostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Radiopharmaceutical Theranostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Radiopharmaceutical Theranostics market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Radiopharmaceutical Theranostics and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Radiopharmaceutical Theranostics.

The global Radiopharmaceutical Theranostics market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Radiopharmaceutical Theranostics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Radiopharmaceutical Theranostics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Radiopharmaceutical Theranostics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Radiopharmaceutical Theranostics players cover Nihon Medi-Physics, ITM Isotopen Technologien M?nchen AG, Advanced Accelerator Applications, Telix Pharmaceuticals, GE Healthcare, Theragnostics Ltd., NuView Life Sciences, Jubilant Pharma Limited and Lantheus Holdings, Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Radiopharmaceutical Theranostics market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type

• Oncology
• Cardiology
• Others

Segmentation by application

• Hospitals
• Academic & Research Institutes
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Nihon Medi-Physics
• ITM Isotopen Technologien M?nchen AG
• Advanced Accelerator Applications
• Telix Pharmaceuticals
• GE Healthcare
• Theragnostics Ltd.
• NuView Life Sciences
• Jubilant Pharma Limited
• Lantheus Holdings, Inc.
• Curium Pharma
• Bayer AG
• Clarity Pharmaceuticals

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Radiopharmaceutical Theranostics Market Size 2018-2029
  2.1.2 Radiopharmaceutical Theranostics Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Radiopharmaceutical Theranostics Segment by Type
  2.2.1 Oncology
  2.2.2 Cardiology
  2.2.3 Others
2.3 Radiopharmaceutical Theranostics Market Size by Type
  2.3.1 Radiopharmaceutical Theranostics Market Size CAGR by Type (2018 VS 2022 VS 2029)
  2.3.2 Global Radiopharmaceutical Theranostics Market Size Market Share by Type (2018-2023)
2.4 Radiopharmaceutical Theranostics Segment by Application
  2.4.1 Hospitals
  2.4.2 Academic & Research Institutes
  2.4.3 Others
2.5 Radiopharmaceutical Theranostics Market Size by Application
  2.5.1 Radiopharmaceutical Theranostics Market Size CAGR by Application (2018 VS 2022 VS 2029)
  2.5.2 Global Radiopharmaceutical Theranostics Market Size Market Share by Application (2018-2023)

3 RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE BY PLAYER

3.1 Radiopharmaceutical Theranostics Market Size Market Share by Players
  3.1.1 Global Radiopharmaceutical Theranostics Revenue by Players (2018-2023)
  3.1.2 Global Radiopharmaceutical Theranostics Revenue Market Share by Players (2018-2023)
3.2 Global Radiopharmaceutical Theranostics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 RADIOPHARMACEUTICAL THERANOSTICS BY REGIONS

4.1 Radiopharmaceutical Theranostics Market Size by Regions (2018-2023)
4.2 Americas Radiopharmaceutical Theranostics Market Size Growth (2018-2023)
4.3 APAC Radiopharmaceutical Theranostics Market Size Growth (2018-2023)
4.4 Europe Radiopharmaceutical Theranostics Market Size Growth (2018-2023)
4.5 Middle East & Africa Radiopharmaceutical Theranostics Market Size Growth (2018-2023)

5 AMERICAS

5.1 Americas Radiopharmaceutical Theranostics Market Size by Country (2018-2023)
5.2 Americas Radiopharmaceutical Theranostics Market Size by Type (2018-2023)
5.3 Americas Radiopharmaceutical Theranostics Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Radiopharmaceutical Theranostics Market Size by Region (2018-2023)
6.2 APAC Radiopharmaceutical Theranostics Market Size by Type (2018-2023)
6.3 APAC Radiopharmaceutical Theranostics Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Radiopharmaceutical Theranostics by Country (2018-2023)
7.2 Europe Radiopharmaceutical Theranostics Market Size by Type (2018-2023)
7.3 Europe Radiopharmaceutical Theranostics Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Radiopharmaceutical Theranostics by Region (2018-2023)
8.2 Middle East & Africa Radiopharmaceutical Theranostics Market Size by Type (2018-2023)
8.3 Middle East & Africa Radiopharmaceutical Theranostics Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL RADIOPHARMACEUTICAL THERANOSTICS MARKET FORECAST

10.1 Global Radiopharmaceutical Theranostics Forecast by Regions (2024-2029)
  10.1.1 Global Radiopharmaceutical Theranostics Forecast by Regions (2024-2029)
  10.1.2 Americas Radiopharmaceutical Theranostics Forecast
  10.1.3 APAC Radiopharmaceutical Theranostics Forecast
  10.1.4 Europe Radiopharmaceutical Theranostics Forecast
  10.1.5 Middle East & Africa Radiopharmaceutical Theranostics Forecast
10.2 Americas Radiopharmaceutical Theranostics Forecast by Country (2024-2029)
  10.2.1 United States Radiopharmaceutical Theranostics Market Forecast
  10.2.2 Canada Radiopharmaceutical Theranostics Market Forecast
  10.2.3 Mexico Radiopharmaceutical Theranostics Market Forecast
  10.2.4 Brazil Radiopharmaceutical Theranostics Market Forecast
10.3 APAC Radiopharmaceutical Theranostics Forecast by Region (2024-2029)
  10.3.1 China Radiopharmaceutical Theranostics Market Forecast
  10.3.2 Japan Radiopharmaceutical Theranostics Market Forecast
  10.3.3 Korea Radiopharmaceutical Theranostics Market Forecast
  10.3.4 Southeast Asia Radiopharmaceutical Theranostics Market Forecast
  10.3.5 India Radiopharmaceutical Theranostics Market Forecast
  10.3.6 Australia Radiopharmaceutical Theranostics Market Forecast
10.4 Europe Radiopharmaceutical Theranostics Forecast by Country (2024-2029)
  10.4.1 Germany Radiopharmaceutical Theranostics Market Forecast
  10.4.2 France Radiopharmaceutical Theranostics Market Forecast
  10.4.3 UK Radiopharmaceutical Theranostics Market Forecast
  10.4.4 Italy Radiopharmaceutical Theranostics Market Forecast
  10.4.5 Russia Radiopharmaceutical Theranostics Market Forecast
10.5 Middle East & Africa Radiopharmaceutical Theranostics Forecast by Region (2024-2029)
  10.5.1 Egypt Radiopharmaceutical Theranostics Market Forecast
  10.5.2 South Africa Radiopharmaceutical Theranostics Market Forecast
  10.5.3 Israel Radiopharmaceutical Theranostics Market Forecast
  10.5.4 Turkey Radiopharmaceutical Theranostics Market Forecast
  10.5.5 GCC Countries Radiopharmaceutical Theranostics Market Forecast
10.6 Global Radiopharmaceutical Theranostics Forecast by Type (2024-2029)
10.7 Global Radiopharmaceutical Theranostics Forecast by Application (2024-2029)

11 KEY PLAYERS ANALYSIS

11.1 Nihon Medi-Physics
  11.1.1 Nihon Medi-Physics Company Information
  11.1.2 Nihon Medi-Physics Radiopharmaceutical Theranostics Product Offered
  11.1.3 Nihon Medi-Physics Radiopharmaceutical Theranostics Revenue, Gross Margin and Market Share (2018-2023)
  11.1.4 Nihon Medi-Physics Main Business Overview
  11.1.5 Nihon Medi-Physics Latest Developments
11.2 ITM Isotopen Technologien M?nchen AG
  11.2.1 ITM Isotopen Technologien M?nchen AG Company Information
  11.2.2 ITM Isotopen Technologien M?nchen AG Radiopharmaceutical Theranostics Product Offered
  11.2.3 ITM Isotopen Technologien M?nchen AG Radiopharmaceutical Theranostics Revenue, Gross Margin and Market Share (2018-2023)
  11.2.4 ITM Isotopen Technologien M?nchen AG Main Business Overview
  11.2.5 ITM Isotopen Technologien M?nchen AG Latest Developments
11.3 Advanced Accelerator Applications
  11.3.1 Advanced Accelerator Applications Company Information
  11.3.2 Advanced Accelerator Applications Radiopharmaceutical Theranostics Product Offered
  11.3.3 Advanced Accelerator Applications Radiopharmaceutical Theranostics Revenue, Gross Margin and Market Share (2018-2023)
  11.3.4 Advanced Accelerator Applications Main Business Overview
  11.3.5 Advanced Accelerator Applications Latest Developments
11.4 Telix Pharmaceuticals
  11.4.1 Telix Pharmaceuticals Company Information
  11.4.2 Telix Pharmaceuticals Radiopharmaceutical Theranostics Product Offered
  11.4.3 Telix Pharmaceuticals Radiopharmaceutical Theranostics Revenue, Gross Margin and Market Share (2018-2023)
  11.4.4 Telix Pharmaceuticals Main Business Overview
  11.4.5 Telix Pharmaceuticals Latest Developments
11.5 GE Healthcare
  11.5.1 GE Healthcare Company Information
  11.5.2 GE Healthcare Radiopharmaceutical Theranostics Product Offered
  11.5.3 GE Healthcare Radiopharmaceutical Theranostics Revenue, Gross Margin and Market Share (2018-2023)
  11.5.4 GE Healthcare Main Business Overview
  11.5.5 GE Healthcare Latest Developments
11.6 Theragnostics Ltd.
  11.6.1 Theragnostics Ltd. Company Information
  11.6.2 Theragnostics Ltd. Radiopharmaceutical Theranostics Product Offered
  11.6.3 Theragnostics Ltd. Radiopharmaceutical Theranostics Revenue, Gross Margin and Market Share (2018-2023)
  11.6.4 Theragnostics Ltd. Main Business Overview
  11.6.5 Theragnostics Ltd. Latest Developments
11.7 NuView Life Sciences
  11.7.1 NuView Life Sciences Company Information
  11.7.2 NuView Life Sciences Radiopharmaceutical Theranostics Product Offered
  11.7.3 NuView Life Sciences Radiopharmaceutical Theranostics Revenue, Gross Margin and Market Share (2018-2023)
  11.7.4 NuView Life Sciences Main Business Overview
  11.7.5 NuView Life Sciences Latest Developments
11.8 Jubilant Pharma Limited
  11.8.1 Jubilant Pharma Limited Company Information
  11.8.2 Jubilant Pharma Limited Radiopharmaceutical Theranostics Product Offered
  11.8.3 Jubilant Pharma Limited Radiopharmaceutical Theranostics Revenue, Gross Margin and Market Share (2018-2023)
  11.8.4 Jubilant Pharma Limited Main Business Overview
  11.8.5 Jubilant Pharma Limited Latest Developments
11.9 Lantheus Holdings, Inc.
  11.9.1 Lantheus Holdings, Inc. Company Information
  11.9.2 Lantheus Holdings, Inc. Radiopharmaceutical Theranostics Product Offered
  11.9.3 Lantheus Holdings, Inc. Radiopharmaceutical Theranostics Revenue, Gross Margin and Market Share (2018-2023)
  11.9.4 Lantheus Holdings, Inc. Main Business Overview
  11.9.5 Lantheus Holdings, Inc. Latest Developments
11.10 Curium Pharma
  11.10.1 Curium Pharma Company Information
  11.10.2 Curium Pharma Radiopharmaceutical Theranostics Product Offered
  11.10.3 Curium Pharma Radiopharmaceutical Theranostics Revenue, Gross Margin and Market Share (2018-2023)
  11.10.4 Curium Pharma Main Business Overview
  11.10.5 Curium Pharma Latest Developments
11.11 Bayer AG
  11.11.1 Bayer AG Company Information
  11.11.2 Bayer AG Radiopharmaceutical Theranostics Product Offered
  11.11.3 Bayer AG Radiopharmaceutical Theranostics Revenue, Gross Margin and Market Share (2018-2023)
  11.11.4 Bayer AG Main Business Overview
  11.11.5 Bayer AG Latest Developments
11.12 Clarity Pharmaceuticals
  11.12.1 Clarity Pharmaceuticals Company Information
  11.12.2 Clarity Pharmaceuticals Radiopharmaceutical Theranostics Product Offered
  11.12.3 Clarity Pharmaceuticals Radiopharmaceutical Theranostics Revenue, Gross Margin and Market Share (2018-2023)
  11.12.4 Clarity Pharmaceuticals Main Business Overview
  11.12.5 Clarity Pharmaceuticals Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Radiopharmaceutical Theranostics Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Oncology
Table 3. Major Players of Cardiology
Table 4. Major Players of Others
Table 5. Radiopharmaceutical Theranostics Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 6. Global Radiopharmaceutical Theranostics Market Size by Type (2018-2023) & ($ Millions)
Table 7. Global Radiopharmaceutical Theranostics Market Size Market Share by Type (2018-2023)
Table 8. Radiopharmaceutical Theranostics Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global Radiopharmaceutical Theranostics Market Size by Application (2018-2023) & ($ Millions)
Table 10. Global Radiopharmaceutical Theranostics Market Size Market Share by Application (2018-2023)
Table 11. Global Radiopharmaceutical Theranostics Revenue by Players (2018-2023) & ($ Millions)
Table 12. Global Radiopharmaceutical Theranostics Revenue Market Share by Player (2018-2023)
Table 13. Radiopharmaceutical Theranostics Key Players Head office and Products Offered
Table 14. Radiopharmaceutical Theranostics Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Radiopharmaceutical Theranostics Market Size by Regions 2018-2023 & ($ Millions)
Table 18. Global Radiopharmaceutical Theranostics Market Size Market Share by Regions (2018-2023)
Table 19. Global Radiopharmaceutical Theranostics Revenue by Country/Region (2018-2023) & ($ millions)
Table 20. Global Radiopharmaceutical Theranostics Revenue Market Share by Country/Region (2018-2023)
Table 21. Americas Radiopharmaceutical Theranostics Market Size by Country (2018-2023) & ($ Millions)
Table 22. Americas Radiopharmaceutical Theranostics Market Size Market Share by Country (2018-2023)
Table 23. Americas Radiopharmaceutical Theranostics Market Size by Type (2018-2023) & ($ Millions)
Table 24. Americas Radiopharmaceutical Theranostics Market Size Market Share by Type (2018-2023)
Table 25. Americas Radiopharmaceutical Theranostics Market Size by Application (2018-2023) & ($ Millions)
Table 26. Americas Radiopharmaceutical Theranostics Market Size Market Share by Application (2018-2023)
Table 27. APAC Radiopharmaceutical Theranostics Market Size by Region (2018-2023) & ($ Millions)
Table 28. APAC Radiopharmaceutical Theranostics Market Size Market Share by Region (2018-2023)
Table 29. APAC Radiopharmaceutical Theranostics Market Size by Type (2018-2023) & ($ Millions)
Table 30. APAC Radiopharmaceutical Theranostics Market Size Market Share by Type (2018-2023)
Table 31. APAC Radiopharmaceutical Theranostics Market Size by Application (2018-2023) & ($ Millions)
Table 32. APAC Radiopharmaceutical Theranostics Market Size Market Share by Application (2018-2023)
Table 33. Europe Radiopharmaceutical Theranostics Market Size by Country (2018-2023) & ($ Millions)
Table 34. Europe Radiopharmaceutical Theranostics Market Size Market Share by Country (2018-2023)
Table 35. Europe Radiopharmaceutical Theranostics Market Size by Type (2018-2023) & ($ Millions)
Table 36. Europe Radiopharmaceutical Theranostics Market Size Market Share by Type (2018-2023)
Table 37. Europe Radiopharmaceutical Theranostics Market Size by Application (2018-2023) & ($ Millions)
Table 38. Europe Radiopharmaceutical Theranostics Market Size Market Share by Application (2018-2023)
Table 39. Middle East & Africa Radiopharmaceutical Theranostics Market Size by Region (2018-2023) & ($ Millions)
Table 40. Middle East & Africa Radiopharmaceutical Theranostics Market Size Market Share by Region (2018-2023)
Table 41. Middle East & Africa Radiopharmaceutical Theranostics Market Size by Type (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Radiopharmaceutical Theranostics Market Size Market Share by Type (2018-2023)
Table 43. Middle East & Africa Radiopharmaceutical Theranostics Market Size by Application (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Radiopharmaceutical Theranostics Market Size Market Share by Application (2018-2023)
Table 45. Key Market Drivers & Growth Opportunities of Radiopharmaceutical Theranostics
Table 46. Key Market Challenges & Risks of Radiopharmaceutical Theranostics
Table 47. Key Industry Trends of Radiopharmaceutical Theranostics
Table 48. Global Radiopharmaceutical Theranostics Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 49. Global Radiopharmaceutical Theranostics Market Size Market Share Forecast by Regions (2024-2029)
Table 50. Global Radiopharmaceutical Theranostics Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 51. Global Radiopharmaceutical Theranostics Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 52. Nihon Medi-Physics Details, Company Type, Radiopharmaceutical Theranostics Area Served and Its Competitors
Table 53. Nihon Medi-Physics Radiopharmaceutical Theranostics Product Offered
Table 54. Nihon Medi-Physics Radiopharmaceutical Theranostics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 55. Nihon Medi-Physics Main Business
Table 56. Nihon Medi-Physics Latest Developments
Table 57. ITM Isotopen Technologien M?nchen AG Details, Company Type, Radiopharmaceutical Theranostics Area Served and Its Competitors
Table 58. ITM Isotopen Technologien M?nchen AG Radiopharmaceutical Theranostics Product Offered
Table 59. ITM Isotopen Technologien M?nchen AG Main Business
Table 60. ITM Isotopen Technologien M?nchen AG Radiopharmaceutical Theranostics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 61. ITM Isotopen Technologien M?nchen AG Latest Developments
Table 62. Advanced Accelerator Applications Details, Company Type, Radiopharmaceutical Theranostics Area Served and Its Competitors
Table 63. Advanced Accelerator Applications Radiopharmaceutical Theranostics Product Offered
Table 64. Advanced Accelerator Applications Main Business
Table 65. Advanced Accelerator Applications Radiopharmaceutical Theranostics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 66. Advanced Accelerator Applications Latest Developments
Table 67. Telix Pharmaceuticals Details, Company Type, Radiopharmaceutical Theranostics Area Served and Its Competitors
Table 68. Telix Pharmaceuticals Radiopharmaceutical Theranostics Product Offered
Table 69. Telix Pharmaceuticals Main Business
Table 70. Telix Pharmaceuticals Radiopharmaceutical Theranostics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 71. Telix Pharmaceuticals Latest Developments
Table 72. GE Healthcare Details, Company Type, Radiopharmaceutical Theranostics Area Served and Its Competitors
Table 73. GE Healthcare Radiopharmaceutical Theranostics Product Offered
Table 74. GE Healthcare Main Business
Table 75. GE Healthcare Radiopharmaceutical Theranostics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 76. GE Healthcare Latest Developments
Table 77. Theragnostics Ltd. Details, Company Type, Radiopharmaceutical Theranostics Area Served and Its Competitors
Table 78. Theragnostics Ltd. Radiopharmaceutical Theranostics Product Offered
Table 79. Theragnostics Ltd. Main Business
Table 80. Theragnostics Ltd. Radiopharmaceutical Theranostics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 81. Theragnostics Ltd. Latest Developments
Table 82. NuView Life Sciences Details, Company Type, Radiopharmaceutical Theranostics Area Served and Its Competitors
Table 83. NuView Life Sciences Radiopharmaceutical Theranostics Product Offered
Table 84. NuView Life Sciences Main Business
Table 85. NuView Life Sciences Radiopharmaceutical Theranostics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 86. NuView Life Sciences Latest Developments
Table 87. Jubilant Pharma Limited Details, Company Type, Radiopharmaceutical Theranostics Area Served and Its Competitors
Table 88. Jubilant Pharma Limited Radiopharmaceutical Theranostics Product Offered
Table 89. Jubilant Pharma Limited Main Business
Table 90. Jubilant Pharma Limited Radiopharmaceutical Theranostics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 91. Jubilant Pharma Limited Latest Developments
Table 92. Lantheus Holdings, Inc. Details, Company Type, Radiopharmaceutical Theranostics Area Served and Its Competitors
Table 93. Lantheus Holdings, Inc. Radiopharmaceutical Theranostics Product Offered
Table 94. Lantheus Holdings, Inc. Main Business
Table 95. Lantheus Holdings, Inc. Radiopharmaceutical Theranostics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 96. Lantheus Holdings, Inc. Latest Developments
Table 97. Curium Pharma Details, Company Type, Radiopharmaceutical Theranostics Area Served and Its Competitors
Table 98. Curium Pharma Radiopharmaceutical Theranostics Product Offered
Table 99. Curium Pharma Main Business
Table 100. Curium Pharma Radiopharmaceutical Theranostics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 101. Curium Pharma Latest Developments
Table 102. Bayer AG Details, Company Type, Radiopharmaceutical Theranostics Area Served and Its Competitors
Table 103. Bayer AG Radiopharmaceutical Theranostics Product Offered
Table 104. Bayer AG Radiopharmaceutical Theranostics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 105. Bayer AG Main Business
Table 106. Bayer AG Latest Developments
Table 107. Clarity Pharmaceuticals Details, Company Type, Radiopharmaceutical Theranostics Area Served and Its Competitors
Table 108. Clarity Pharmaceuticals Radiopharmaceutical Theranostics Product Offered
Table 109. Clarity Pharmaceuticals Main Business
Table 110. Clarity Pharmaceuticals Radiopharmaceutical Theranostics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 111. Clarity Pharmaceuticals Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Radiopharmaceutical Theranostics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Radiopharmaceutical Theranostics Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Radiopharmaceutical Theranostics Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Radiopharmaceutical Theranostics Sales Market Share by Country/Region (2022)
Figure 8. Radiopharmaceutical Theranostics Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Radiopharmaceutical Theranostics Market Size Market Share by Type in 2022
Figure 10. Radiopharmaceutical Theranostics in Hospitals
Figure 11. Global Radiopharmaceutical Theranostics Market: Hospitals (2018-2023) & ($ Millions)
Figure 12. Radiopharmaceutical Theranostics in Academic & Research Institutes
Figure 13. Global Radiopharmaceutical Theranostics Market: Academic & Research Institutes (2018-2023) & ($ Millions)
Figure 14. Radiopharmaceutical Theranostics in Others
Figure 15. Global Radiopharmaceutical Theranostics Market: Others (2018-2023) & ($ Millions)
Figure 16. Global Radiopharmaceutical Theranostics Market Size Market Share by Application in 2022
Figure 17. Global Radiopharmaceutical Theranostics Revenue Market Share by Player in 2022
Figure 18. Global Radiopharmaceutical Theranostics Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Radiopharmaceutical Theranostics Market Size 2018-2023 ($ Millions)
Figure 20. APAC Radiopharmaceutical Theranostics Market Size 2018-2023 ($ Millions)
Figure 21. Europe Radiopharmaceutical Theranostics Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Radiopharmaceutical Theranostics Market Size 2018-2023 ($ Millions)
Figure 23. Americas Radiopharmaceutical Theranostics Value Market Share by Country in 2022
Figure 24. United States Radiopharmaceutical Theranostics Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Radiopharmaceutical Theranostics Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Radiopharmaceutical Theranostics Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Radiopharmaceutical Theranostics Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Radiopharmaceutical Theranostics Market Size Market Share by Region in 2022
Figure 29. APAC Radiopharmaceutical Theranostics Market Size Market Share by Type in 2022
Figure 30. APAC Radiopharmaceutical Theranostics Market Size Market Share by Application in 2022
Figure 31. China Radiopharmaceutical Theranostics Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Radiopharmaceutical Theranostics Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Radiopharmaceutical Theranostics Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Radiopharmaceutical Theranostics Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Radiopharmaceutical Theranostics Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Radiopharmaceutical Theranostics Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Radiopharmaceutical Theranostics Market Size Market Share by Country in 2022
Figure 38. Europe Radiopharmaceutical Theranostics Market Size Market Share by Type (2018-2023)
Figure 39. Europe Radiopharmaceutical Theranostics Market Size Market Share by Application (2018-2023)
Figure 40. Germany Radiopharmaceutical Theranostics Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Radiopharmaceutical Theranostics Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Radiopharmaceutical Theranostics Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Radiopharmaceutical Theranostics Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Radiopharmaceutical Theranostics Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Radiopharmaceutical Theranostics Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Radiopharmaceutical Theranostics Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Radiopharmaceutical Theranostics Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Radiopharmaceutical Theranostics Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Radiopharmaceutical Theranostics Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Radiopharmaceutical Theranostics Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Radiopharmaceutical Theranostics Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Radiopharmaceutical Theranostics Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Radiopharmaceutical Theranostics Market Size 2024-2029 ($ Millions)
Figure 54. APAC Radiopharmaceutical Theranostics Market Size 2024-2029 ($ Millions)
Figure 55. Europe Radiopharmaceutical Theranostics Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Radiopharmaceutical Theranostics Market Size 2024-2029 ($ Millions)
Figure 57. United States Radiopharmaceutical Theranostics Market Size 2024-2029 ($ Millions)
Figure 58. Canada Radiopharmaceutical Theranostics Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Radiopharmaceutical Theranostics Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Radiopharmaceutical Theranostics Market Size 2024-2029 ($ Millions)
Figure 61. China Radiopharmaceutical Theranostics Market Size 2024-2029 ($ Millions)
Figure 62. Japan Radiopharmaceutical Theranostics Market Size 2024-2029 ($ Millions)
Figure 63. Korea Radiopharmaceutical Theranostics Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Radiopharmaceutical Theranostics Market Size 2024-2029 ($ Millions)
Figure 65. India Radiopharmaceutical Theranostics Market Size 2024-2029 ($ Millions)
Figure 66. Australia Radiopharmaceutical Theranostics Market Size 2024-2029 ($ Millions)
Figure 67. Germany Radiopharmaceutical Theranostics Market Size 2024-2029 ($ Millions)
Figure 68. France Radiopharmaceutical Theranostics Market Size 2024-2029 ($ Millions)
Figure 69. UK Radiopharmaceutical Theranostics Market Size 2024-2029 ($ Millions)
Figure 70. Italy Radiopharmaceutical Theranostics Market Size 2024-2029 ($ Millions)
Figure 71. Russia Radiopharmaceutical Theranostics Market Size 2024-2029 ($ Millions)
Figure 72. Spain Radiopharmaceutical Theranostics Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Radiopharmaceutical Theranostics Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Radiopharmaceutical Theranostics Market Size 2024-2029 ($ Millions)
Figure 75. Israel Radiopharmaceutical Theranostics Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Radiopharmaceutical Theranostics Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Radiopharmaceutical Theranostics Market Size 2024-2029 ($ Millions)
Figure 78. Global Radiopharmaceutical Theranostics Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Radiopharmaceutical Theranostics Market Size Market Share Forecast by Application (2024-2029)